|Slideshows|November 16, 2020

Statistics of Suicide

Here are some statistics around suicide to help put things in perspective.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

I Wanted to Die. Now, I Help Others Choose Life.

ByDiana Guzman, LMHC-QS, MCAP, CCTP, CCATP

January 15th 2026

FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs

ByLeah Kuntz

January 13th 2026

Accident, or Is It? The Watershed Area Between Trauma and Suicide

ByVanessa Alkarra, BSA,Ynhi Thomas, MD, MPH, MSc,Nidal Moukaddam, MD, PhD

January 9th 2026

CAPS: A New Program to Support Early Intervention in Patients at Risk for Suicide

ByLeah Kuntz

December 15th 2025

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

ByAndrew Nguyen, MD, MSc,Ayal Schaffer, MD, FRCPC

November 26th 2025

Latest CME

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Statistics of Suicide

Newsletter

Related Content

I Wanted to Die. Now, I Help Others Choose Life.

FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs

Accident, or Is It? The Watershed Area Between Trauma and Suicide

CAPS: A New Program to Support Early Intervention in Patients at Risk for Suicide

Through the Peaks and Valleys: Assessing and Addressing Suicide Risk in Bipolar Disorder

Latest CME

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Trending on Psychiatric Times

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap

January 2026 in Review: Updates on the Psychiatric Treatment Pipeline

Is the DSM Helping or Hindering Patient Care? Rethinking Diagnosis, FDA Approval, and Access to Treatment

Updating the DSM: Reviewing the New APA DSM Recommendations

Addressing Co-Occurring ADHD and Autism, With Lauren Kenworthy, PhD